Kusajili – Clinical trials directory

Result of your search per sponsor: Pfizer Inc. 235 East 42nd Street NY10017

Woman and Man Max 99 years
Pfizer Inc. 235 East 42nd Street NY10017 Update Il y a 4 ans

A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF CE-224,535, AN ANTAGONIST OF THE P2X7 RECEPTOR, IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS IN SUBJECTS WHO ARE INADEQUATELY CONTROLLED ON METHOTREXATE The primary objective of this study is to test the efficacy of CE-224,535 vs placebo as assessed by the American College of Rheumatology 20 (ACR 20) Response Rate at 12 weeks in RA subjects inadequate...

Country None
organs None
Specialty None

unknown

More information